Literature DB >> 1657510

Spread and control of Aujeszky's disease (AD).

G Wittmann1.   

Abstract

The review deals with practical aspects of control and eradication of Aujeszky's disease (AD) and the various factors concerned with it. These are resistance of virus to environmental conditions, amounts of virus necessary for infection, virus excretion, virus latency, mode of virus transmission, and vaccination. Notification of AD is a precondition of control. Several measures are necessary on the infected farm to prevent virus spread. Eradication can be done by slaughter of all the seropositive animals. However, until recently this is impossible in severely infected vaccinated areas on economic reasons. The development of glycoprotein-deleted vaccines now allows the differentiation between vaccinated and infected animals by ELISA. Thus, a combination of vaccination and removal of infected pigs is possible, resulting in a more economic way of expanded eradication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657510     DOI: 10.1016/0147-9571(91)90129-2

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  10 in total

1.  Growth, physicochemical properties, and morphogenesis of Chinese wild-type PRV Fa and its gene-deleted mutant strain PRV SA215.

Authors:  Ling Zhu; Yue Yi; Zhiwen Xu; Lu Cheng; Shanhu Tang; Wanzhu Guo
Journal:  Virol J       Date:  2011-06-04       Impact factor: 4.099

2.  Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus.

Authors:  S L Brockmeier; W L Mengeling
Journal:  Can J Vet Res       Date:  1996-10       Impact factor: 1.310

3.  Age-Dependent Differences in Pseudorabies Virus Neuropathogenesis and Associated Cytokine Expression.

Authors:  Sara Verpoest; Brigitte Cay; Herman Favoreel; Nick De Regge
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.

Authors:  W L Mengeling; S L Brockmeier; K M Lager
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.

Authors:  S Heffner; F Kovács; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Expression and purification of Suid Herpesvirus-1 glycoprotein E in the baculovirus system and its use to diagnose Aujeszky's disease in infected pigs.

Authors:  María Soledad Serena; Christoph Geisler; Germán Ernesto Metz; Santiago Gerardo Corva; Eduardo Carlos Mórtola; Alejandra Larsen; Donald L Jarvis; María Gabriela Echeverría
Journal:  Protein Expr Purif       Date:  2013-04-28       Impact factor: 1.650

7.  Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expression.

Authors:  K L Glazenburg; B P Peeters; J M Pol; A L Gielkens; R J Moormann
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  Pathogenic pseudorabies virus, China, 2012.

Authors:  Xiuling Yu; Zhi Zhou; Dongmei Hu; Qian Zhang; Tao Han; Xiaoxia Li; Xiaoxue Gu; Lin Yuan; Shuo Zhang; Baoyue Wang; Ping Qu; Jinhua Liu; Xinyan Zhai; Kegong Tian
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

9.  A 2,5-Dihydroxybenzoic Acid-Gelatin Conjugate: The Synthesis, Antiviral Activity and Mechanism of Antiviral Action Against Two Alphaherpesviruses.

Authors:  Alexander Lisov; Veronika Vrublevskaya; Zoy Lisova; Alexey Leontievsky; Oleg Morenkov
Journal:  Viruses       Date:  2015-10-15       Impact factor: 5.048

10.  Effects of physical and chemical factors on pseudorabies virus activity in vitro.

Authors:  Lang Gong; Qiwei Deng; Runda Xu; Chihai Ji; Heng Wang; Guihong Zhang
Journal:  BMC Vet Res       Date:  2020-09-25       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.